Mar 25, 2021 4:10 pm EDT CymaBay Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update
Mar 12, 2021 8:00 am EST CymaBay Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, March 25, 2021
Feb 10, 2021 8:00 am EST CymaBay Therapeutics to Present at the SVB Leerink 10th Annual Global Healthcare Conference
Nov 16, 2020 4:01 pm EST CymaBay Therapeutics Announces Oral Late-Breaking Presentation of Positive Results from the ENHANCE Global Phase 3 Study Evaluating Seladelpar for Primary Biliary Cholangitis at The Liver Meeting® 2020
Nov 05, 2020 4:05 pm EST CymaBay Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Nov 05, 2020 8:00 am EST CymaBay Announces Study to Evaluate the Potential for GPR119 Agonists to Prevent Hypoglycemia in Type 1 Diabetes